S.I. No. 124/2012 - National Treasury Management Agency (Delegation of Claims Management Functions) (Amendment) Order 2012.
Notice of the making of this Statutory Instrument was published in | ||
“Iris Oifigiúil” of 17th April, 2012. | ||
The Government, at the request of the Minister for Health (being a Minister in whom functions in relation to a State authority are vested) and in exercise of the powers conferred on them by section 9 (1) of the National Treasury Management Agency (Amendment) Act 2000 (No. 39 of 2000), hereby order as follows: | ||
1. (1) This Order may be cited as the National Treasury Management Agency (Delegation of Claims Management Functions) (Amendment) Order 2012. | ||
(2) This Order comes into operation on 3 April 2012. | ||
2. In this Order— | ||
“Order of 2011” means National Treasury Management Agency (Delegation of Claims Management Functions) Order 2011 ( S.I. No. 69 of 2011 ); | ||
“Order of 2009” means National Treasury Management Agency (Delegation of Functions) Order 2009 ( S.I. No. 586 of 2009 ). | ||
3. The Order of 2011 is amended by inserting after Article 4 the following: | ||
“4A. Notwithstanding the generality of Article 4, the exemption provided for in Article 4(b)(i) does not apply in respect of personal injury claims which include a claim in relation to liability for the medicinal products thalidomide and nimesulide.”. | ||
4. The Order of 2009 is amended in Regulation 6 by substituting the following for paragraph (b): | ||
“(b) claims in respect of personal injury in relation to liability for defective products, other than the medicinal products thalidomide and nimesulide, or intentional infliction of mental suffering.”. | ||
| ||
GIVEN under the Official Seal of the Government, | ||
3 April 2012. | ||
ENDA KENNY, | ||
Taoiseach. | ||
EXPLANATORY NOTE | ||
(This note is not part of the instrument and does not purport to be a legal instrument.) | ||
Certain classes of claims are exempt from delegation to the National Treasury Management Agency. This Order removes claims in relation to the medicinal products thalidomide and nimesulide from the exemption. |